US 11905276
Bicyclic compound that acts as CRBN protein regulator
granted A61KA61K31/443A61P
Quick answer
US patent 11905276 (Bicyclic compound that acts as CRBN protein regulator) held by Medshine Discovery Inc. expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/443, A61P, A61P35/00, A61P35/02